Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2026, Vol. 31 ›› Issue (4): 460-466.doi: 10.12092/j.issn.1009-2501.2026.04.004
Previous Articles Next Articles
Jiawang YU1(
), Guomei LI1, Changbao HUANG2, Ning TANG1, Weihua LU3, Feng ZHOU1,*(
)
Received:2025-07-05
Revised:2025-10-24
Online:2026-04-26
Published:2026-04-30
Contact:
Feng ZHOU
E-mail:20201225@wnmc.edu.cn;251959931@qq.com
CLC Number:
Jiawang YU, Guomei LI, Changbao HUANG, Ning TANG, Weihua LU, Feng ZHOU. Study on a nomogram model for predicting the prognosis of patients with acute organophosphorus pesticide poisoning in Southern Anhui[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(4): 460-466.
| 特征(Characteristics) | 好转 | 死亡 | P值 (P value) | |
| 性别(Gender) | 男 | 30 | 3 | 0.338 |
| 女 | 35 | 7 | ||
| 年龄(Age) | 67.5±4.7 | 75.5±4.5 | 0.006 | |
| GCS评分(GCS score) | 14.3±1.7 | 14.7±0.9 | 0.496 | |
| 心率(Heart rate) | 89.5±20.2 | 87.9±27.4 | 0.827 | |
| 收缩压(SBP) | 137.4±23.9 | 140.9±25.8 | 0.679 | |
| 舒张压(DBP) | 81.1±13.9 | 75.5±14.1 | 0.250 | |
| 呼吸频率(Respiratory rate) | 19.9±9.2 | 17.5±1.7 | 0.423 | |
| 血氧分压(SPO2) | 96.6±3.1 | 95.3±2.8 | 0.222 | |
| CO2结合力(CO2CP) | 17.8±6.1 | 15.31±4.8 | 0.222 | |
| 肌酸激酶(CK) | 161.3±117.3 | 96.4±69.3 | 0.097 | |
| 肌酸激酶同工酶-MB(CKMB) | 31.8±36.8 | 38.3±64.7 | 0.653 | |
| 乳酸脱氢酶(LDH) | 235.4±71.5 | 242.8±84.4 | 0.769 | |
| 白细胞总数(WBC) | 11.5±9.8 | 14.2±7.4 | 0.407 | |
| 中性粒细胞百分比[n(%)] | 79.5±13.8 | 80.9±19.7 | 0.781 | |
| 红细胞(RBC) | 4.1±0.6 | 3.9±0.6 | 0.280 | |
| 血红蛋白(HB) | 125.9±19.8 | 118.5±18.8 | 0.276 | |
| 血小板(PLT) | 175.4±74.4 | 171.2±46.5 | 0.866 | |
| C反应蛋白(CRP) | 31.4±49.5 | 29.1±31.8 | 0.888 | |
| 肌酐(CRE) | 71. 8±26.1 | 103.2±73.6 | 0.014 | |
| 天冬氨酸氨基转移酶(AST) | 27.1±19. 1 | 35.8±49.7 | 0.322 | |
| 丙氨酸氨基转移酶(ALT) | 20.1±18.1 | 26.4±28.6 | 0.359 | |
| 胆碱酯酶(CHE) | 0.015 | |||
Table 1 Baseline characteristics of patients with organophosphate poisoning who improved and those who died
| 特征(Characteristics) | 好转 | 死亡 | P值 (P value) | |
| 性别(Gender) | 男 | 30 | 3 | 0.338 |
| 女 | 35 | 7 | ||
| 年龄(Age) | 67.5±4.7 | 75.5±4.5 | 0.006 | |
| GCS评分(GCS score) | 14.3±1.7 | 14.7±0.9 | 0.496 | |
| 心率(Heart rate) | 89.5±20.2 | 87.9±27.4 | 0.827 | |
| 收缩压(SBP) | 137.4±23.9 | 140.9±25.8 | 0.679 | |
| 舒张压(DBP) | 81.1±13.9 | 75.5±14.1 | 0.250 | |
| 呼吸频率(Respiratory rate) | 19.9±9.2 | 17.5±1.7 | 0.423 | |
| 血氧分压(SPO2) | 96.6±3.1 | 95.3±2.8 | 0.222 | |
| CO2结合力(CO2CP) | 17.8±6.1 | 15.31±4.8 | 0.222 | |
| 肌酸激酶(CK) | 161.3±117.3 | 96.4±69.3 | 0.097 | |
| 肌酸激酶同工酶-MB(CKMB) | 31.8±36.8 | 38.3±64.7 | 0.653 | |
| 乳酸脱氢酶(LDH) | 235.4±71.5 | 242.8±84.4 | 0.769 | |
| 白细胞总数(WBC) | 11.5±9.8 | 14.2±7.4 | 0.407 | |
| 中性粒细胞百分比[n(%)] | 79.5±13.8 | 80.9±19.7 | 0.781 | |
| 红细胞(RBC) | 4.1±0.6 | 3.9±0.6 | 0.280 | |
| 血红蛋白(HB) | 125.9±19.8 | 118.5±18.8 | 0.276 | |
| 血小板(PLT) | 175.4±74.4 | 171.2±46.5 | 0.866 | |
| C反应蛋白(CRP) | 31.4±49.5 | 29.1±31.8 | 0.888 | |
| 肌酐(CRE) | 71. 8±26.1 | 103.2±73.6 | 0.014 | |
| 天冬氨酸氨基转移酶(AST) | 27.1±19. 1 | 35.8±49.7 | 0.322 | |
| 丙氨酸氨基转移酶(ALT) | 20.1±18.1 | 26.4±28.6 | 0.359 | |
| 胆碱酯酶(CHE) | 0.015 | |||
| 特征(Characteristics) | 风险比(HR) | 95%置信区间(95%CI) | P值(P value) |
| 性别(Gender) | 0.53 | 0.14~2.04 | 0.354 |
| 年龄(Age) | 1.08 | 1.02~1.16 | 0.015 |
| GCS评分(GCS score) | 1.21 | 0.69~2.12 | 0.500 |
| 心率(Heart rate) | 1.00 | 0.97~1.03 | 0.833 |
| 收缩压(SBP) | 1.01 | 0.98~1.03 | 0.684 |
| 舒张压(DBP) | 0.97 | 0.93~1.02 | 0.246 |
| 呼吸频率(Respiratory rate) | 0.78 | 0.57~1.06 | 0.107 |
| 血氧分压(SPO2) | 0.92 | 0.80~1.06 | 0.244 |
| CO2结合力(CO2CP) | 0.94 | 0.85~1.05 | 0.257 |
| 肌酸激酶(CK) | 0.99 | 0.98~1.00 | 0.101 |
| 肌酸激酶同工酶-MB(CKMB) | 1.00 | 0.99~1.02 | 0.715 |
| 乳酸脱氢酶(LDH) | 1.00 | 0.99~1.01 | 0.810 |
| 白细胞总数(WBC) | 1.02 | 0.97~1.06 | 0.440 |
| 中性粒细胞百分比[n(%)] | 1.01 | 0.96~1.05 | 0.781 |
| 红细胞(RBC) | 0.56 | 0.19~1.65 | 0.292 |
| 血红蛋白(HB) | 0.98 | 0.95~1.01 | 0.274 |
| 血小板(PLT) | 1.00 | 0.99~1.01 | 0.833 |
| C反应蛋白(CRP) | 1.00 | 0.99~1.01 | 0.848 |
| 肌酐(CRE) | 1.03 | 1.02~1.05 | 0.016 |
| 天冬氨酸氨基转移酶(AST) | 1.01 | 0.99~1.02 | 0.350 |
| 丙氨酸氨基转移酶(ALT) | 1.01 | 0.99~1.03 | 0.376 |
| 胆碱酯酶(CHE) | 0.98 | 0.97~0.99 | 0.025 |
Table 2 Univariate Cox analysis of prognostic characteristics in patients with organophosphate poisoning
| 特征(Characteristics) | 风险比(HR) | 95%置信区间(95%CI) | P值(P value) |
| 性别(Gender) | 0.53 | 0.14~2.04 | 0.354 |
| 年龄(Age) | 1.08 | 1.02~1.16 | 0.015 |
| GCS评分(GCS score) | 1.21 | 0.69~2.12 | 0.500 |
| 心率(Heart rate) | 1.00 | 0.97~1.03 | 0.833 |
| 收缩压(SBP) | 1.01 | 0.98~1.03 | 0.684 |
| 舒张压(DBP) | 0.97 | 0.93~1.02 | 0.246 |
| 呼吸频率(Respiratory rate) | 0.78 | 0.57~1.06 | 0.107 |
| 血氧分压(SPO2) | 0.92 | 0.80~1.06 | 0.244 |
| CO2结合力(CO2CP) | 0.94 | 0.85~1.05 | 0.257 |
| 肌酸激酶(CK) | 0.99 | 0.98~1.00 | 0.101 |
| 肌酸激酶同工酶-MB(CKMB) | 1.00 | 0.99~1.02 | 0.715 |
| 乳酸脱氢酶(LDH) | 1.00 | 0.99~1.01 | 0.810 |
| 白细胞总数(WBC) | 1.02 | 0.97~1.06 | 0.440 |
| 中性粒细胞百分比[n(%)] | 1.01 | 0.96~1.05 | 0.781 |
| 红细胞(RBC) | 0.56 | 0.19~1.65 | 0.292 |
| 血红蛋白(HB) | 0.98 | 0.95~1.01 | 0.274 |
| 血小板(PLT) | 1.00 | 0.99~1.01 | 0.833 |
| C反应蛋白(CRP) | 1.00 | 0.99~1.01 | 0.848 |
| 肌酐(CRE) | 1.03 | 1.02~1.05 | 0.016 |
| 天冬氨酸氨基转移酶(AST) | 1.01 | 0.99~1.02 | 0.350 |
| 丙氨酸氨基转移酶(ALT) | 1.01 | 0.99~1.03 | 0.376 |
| 胆碱酯酶(CHE) | 0.98 | 0.97~0.99 | 0.025 |
| 特征(Characteristics) | 系数(Coefficients) |
| 年龄(Age) | |
| 肌酐(CRE) | |
| 胆碱酯酶(CHE) | ? |
Table 3 Results of LASSO Cox analysis
| 特征(Characteristics) | 系数(Coefficients) |
| 年龄(Age) | |
| 肌酐(CRE) | |
| 胆碱酯酶(CHE) | ? |
| 1 |
Yu SY, Gao YX, Walline J, et al. Role of penehyclidine in acute organophosphorus pesticide poisoning[J]. World J Emerg Med, 2020, 11 (1): 37- 47.
doi: 10.5847/wjem.j.1920-8642.2020.01.006 |
| 2 |
Eddleston M, Buckley NA, Eyer P, et al. Management of acute organophosphorus pesticide poisoning[J]. Lancet, 2008, 371 (9612): 597- 607.
doi: 10.1016/S0140-6736(07)61202-1 |
| 3 |
Hulse EJ, Haslam JD, Emmett SR, et al. Organophosphorus nerve agent poisoning: managing the poisoned patient[J]. Br J Anaesth, 2019, 123 (4): 457- 463.
doi: 10.1016/j.bja.2019.04.061 |
| 4 |
Wu X, Xie W, Cheng Y, et al. Severity and prognosis of acute organophosphorus pesticide poisoning are indicated by C-reactive protein and copeptin levels and APACHE II score[J]. Exp Ther Med, 2016, 11 (3): 806- 810.
doi: 10.3892/etm.2016.2982 |
| 5 | 中国医师协会急诊医师分会. 急性有机磷农药中毒诊治临床专家共识(2016) [J]. 中国急救医学, 2016, 36(12): 1057-1065. |
| 6 |
Tang W, Ruan F, Chen Q, et al. Independent prognostic factors for acute organophosphorus pesticide poisoning[J]. Respir Care, 2016, 61 (7): 965- 970.
doi: 10.4187/respcare.04514 |
| 7 |
Schliebs R, Arendt T. The cholinergic system in aging and neuronal degeneration[J]. Behav Brain Res, 2011, 221 (2): 555- 563.
doi: 10.1016/j.bbr.2010.11.058 |
| 8 |
Lee FY, Chen WK, Lin CL, et al. Organophosphate poisoning and subsequent acute kidney injury risk: a nationwide population-based cohort study[J]. Medicine (Baltimore), 2015, 94 (47): e2107.
doi: 10.1097/MD.0000000000002107 |
| 9 |
Jacobson MH, Wu Y, Liu M, et al. Organophosphate pesticides and progression of chronic kidney disease among children: a prospective cohort study[J]. Environ Int, 2021, 155, 106597.
doi: 10.1016/j.envint.2021.106597 |
| 10 |
Noh E, Moon JM, Chun BJ, et al. The clinical role of serum albumin in organophospate poisoning[J]. Basic Clin Pharmacol Toxicol, 2021, 128 (4): 605- 614.
doi: 10.1111/bcpt.13546 |
| 11 |
Badr AM. Organophosphate toxicity: updates of malathion potential toxic effects in mammals and potential treatments[J]. Environ Sci Pollut Res Int, 2020, 27 (21): 26036- 26057.
doi: 10.1007/s11356-020-08937-4 |
| 12 |
Medina-Buelvas D, Estrada-Muñiz E, Flores-Valadez M, et al. Genotoxic and immunotoxic effects of the organophosphate metabolite diethyldithiophosphate (DEDTP) in vivo[J]. Toxicol Appl Pharmacol, 2019, 366, 96- 103.
doi: 10.1016/j.taap.2019.01.023 |
| 13 |
Huang MJ, Ye DX, Lin Y, et al. A nomogram for predicting rectovaginal fistula after low anterior resection for rectal cancer[J]. Surg Today, 2020, 50 (10): 1206- 1212.
doi: 10.1007/s00595-020-02049-9 |
| 14 |
An C, Huang Z, Ni J, et al. Development and validation of a clinicopathological-based nomogram to predict seeding risk after percutaneous thermal ablation of primary liver carcinoma[J]. Cancer Med, 2020, 9 (18): 6497- 6506.
doi: 10.1002/cam4.3250 |
| 15 |
Dong N, Wang S, Li X, et al. Prognostic nomogram for the severity of acute organophosphate insecticide self-poisoning: a retrospective observational cohort study[J]. BMJ Open, 2021, 11 (5): e042765.
doi: 10.1136/bmjopen-2020-042765 |
| [1] | Shouyan HE, Minjun LIU, Cong WAN, Buzhen TAN. Research progress of PARP inhibitors therapy for endometrial cancer [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(4): 536-542. |
| [2] | Qianmin ZENG, Jiejun ZHAO, Yaming XI. Research status of immunoparesis in multiple myeloma [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2026, 31(4): 561-567. |
| [3] | WEI Yuanyuan1, MA Tao1, TANG Yuezhou1, LI Hubo1, 2, TIAN Xiaoyu1, 2, DANG Yunjie1, ZHOU Xu1. Individualized dosage study of vitamin D3 based on physiologically-based pharmacokinetic modeling [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(8): 1067-1075. |
| [4] | DING Qin, YANG Ruwei, ZHANG Shengnan, YANG Guoping, PEI Qi. Time-to-event analysis in evaluating the efficacy of drugs against multidrug-resistant gram-negative bacterial infections [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(7): 998-1008. |
| [5] | WANG Feng, LIANG Luhua, ZHAI Fei, LUO Xiaoling, XIANG Rongwu. Construction of a comprehensive prediction and visualization system for drug resistance in pulmonary tuberculosis patients based on an improved machine learning model [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(5): 673-682. |
| [6] | XU Tingting, WANG Wanjie, BAO Jing, XIA Ruixiang. The relationship between NLRC4-mediated inflammasome pathway and multiple myeloma and its therapeutic prospect [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(4): 501-508. |
| [7] | TAN Yanchen, WANG Wenwen, XIA Jielai, LI Chen. Research on the application of machine learning algorithms in anticancer drug response prediction [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(2): 200-208. |
| [8] | CAO Shang, RAO Yuqing, DONG Chenglong, LI Ziwei, KAN Hongwei. Pharmacovigilance of antibody drugs: Bayesian network practice [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(11): 1541-1549. |
| [9] | ZHOU Juxiang, LI Yanfei, LV Fangjun, LI Daitian, ZHANG Jihong, WU Jichu. Construction of a risk prediction model for high plasma concentration of voriconazole [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(6): 653-660. |
| [10] | WANG Mengjiao, GAO Chao, WANG Tao, ZHANG Qian, WEN Juan, LV Dongmei, HU Lili. CDA C435T gene polymorphism significantly extends the long-term efficacy of gemcitabine in advanced non-small cell lung cancer [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(12): 1337-1343. |
| [11] | CHEN Ye, JIANG Yingshuo, ZHU Xinyue, DU Wenxin, CHEN Xin, LOU Sheng, SUN Jianguo, ZHU Junrong. Construction and evaluation of dynamic nomogram model prediction model for early acute renal injury risk after heart transplantation [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(11): 1272-1279. |
| [12] | SHI Dawei, ZHENG Xiaoyong, JIN Xiaodan, ZHAO Xiaoman, CHEN Jie, DU Xingjun. Implication of XPC rs2228001 polymorphism on the prognosis of patients with colorectal cancer who were treated with capecitabine-based adjuvant chemotherapy [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(4): 391-399. |
| [13] | HUANG Kaige, XU Qinhua, WANG Wei. Interaction effect and predictive efficacy of blood glucose and blood calcium on the prognosis of patients with acute severe pancreatitis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1227-1234. |
| [14] | HUANG Xiaoming, DU Ye, LIN Shaoming, SHEN Guanle. Exploratory study of the influence of respiratory microbiology on the efficacy of PD-1 inhibitors monotherapy for patients with advanced non-small cell lung cancer [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(1): 66-74. |
| [15] | LIAN Jinfang, LIU Yiwei, LIN Cuihong, HUANG Pinfang, LIN Rongfang. Comparison of prediction accuracy between warfarin PPK/PD model and multiple regression dose models [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(3): 267-273. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||